TECH & INNOVATION

Ora, Inc.

BRIM Biotechnology, Inc. and Ora, Inc. Announce New Partnership to Accelerate the Development of Regenerative Peptide Therapy, BRM421 for Dry Eye Syndrome

Medicine & Technology BRIM Biotechnology, Inc. ("BRIM") a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®, Inc. ("ORA") the world's leading, ophthalmic research organization, for the late-stage clinical development of lead drug candidate, BRM421, for dry eye syndrome (DES). BRIM intends to initiate Phase 3 clinical studies with Ora's support later this year.
verano Brands

Verano Launches Mobile Applications and Exclusive Rewards Programs for Flagship Zen Leaf and MÜV Cannabis Dispensaries

Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) ("Verano" or the "Company"), a leading multi-state cannabis company, today announced the launch of mobile applications for the Company's flagship Zen Leaf and MÜV dispensaries, unlocking an additional digital channel for shoppers to order cannabis products and access exclusive rewards across a total of 71 dispensaries in seven states.

Recommended Stories

Real Time Analytics